Log in to save to my catalogue

Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Carergot) in the...

Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Carergot) in the...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_194914229

Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Carergot) in the acute treatment of migraine: A multicentre, randomised, double-blind

About this item

Full title

Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Carergot) in the acute treatment of migraine: A multicentre, randomised, double-blind

Publisher

Basel: S. Karger AG

Journal title

European neurology, 2002-02, Vol.47 (2), p.99

Language

English

Formats

Publication information

Publisher

Basel: S. Karger AG

More information

Scope and Contents

Contents

The 5-HT(1B/1D/1F) agonist eletriptan, at an oral dose of 80 mg, has been shown to be more efficacious than sumatriptan 100 mg and placebo in the treatment of migraine attacks with or without aura. Another commonly prescribed oral treatment for migraine attacks is Cafergot (1 mg ergotamine tartrate with 100 mg caffeine per tablet). The efficacy, to...

Alternative Titles

Full title

Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Carergot) in the acute treatment of migraine: A multicentre, randomised, double-blind

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_194914229

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_194914229

Other Identifiers

ISSN

0014-3022

E-ISSN

1421-9913

How to access this item